Earnings History Data for Leap Therapeutics (LPTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Leap Therapeutics
Leap Therapeutics, Inc. is a biopharmaceutical company. It develops novel therapeutics for the treatment of cancer. Leap Therapeutics, Inc. is based in Cambridge, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-11-2024 | PM | LPTX | Leap Therapeutics | 84.00 | -0.44 | -0.46 | 0.00 | Leap Therapeutics GAAP EPS of -$0.44 beats by $0.04 [11/13/2024 7:26 AM] |
2.99 | -0.26 (-8.00%) |
3.30 | 0.05 (1.54%) |
1.32 - 5.00 | 429,701 | 340,000 | 4,207 | ||
| 13-05-2024 | PM | LPTX | Leap Therapeutics | 75.00 | -0.51 | -0.57 | 0.00 | 2.87 | 0.09 (3.24%) |
2.79 | 0.01 (0.36%) |
1.24 - 10.20 | 195,138 | 170,000 | 1,174 | |||
|
|
||||||||||||||||||
| 18-03-2024 | PM | LPTX | Leap Therapeutics | 56.00 | -0.46 | -0.56 | 0.00 | Leap Therapeutics GAAP EPS of -$0.46 beats by $0.10 [3/18/2024 7:10 AM] |
2.16 | -0.05 (-2.26%) |
2.21 | 0.0 (0.00%) |
1.24 - 10.20 | 136,323 | 180,000 | 5,370 | ||
| 12-11-2021 | PM | LPTX | LEAP THERAPEUTICS, INC. | 219.94 | -0.14 | -0.11 | -0.09 | Leap Therapeutics reports Q3 results [11/12/2021 7:40 AM] |
2.45 | 0.07 (2.72%) |
2.42 | 0.03 (1.26%) |
1.33 - 4.17 | 2,867,333 | 1,310,000 | 21,602 | ||
| 13-08-2021 | PM | LPTX | LEAP THERAPEUTICS, INC. | 94.28 | -0.12 | -0.13 | -0.12 | Leap Therapeutics EPS in-line, beats on revenue [8/13/2021 7:19 AM] |
1.68 | 0.02 (1.20%) |
1.66 | 0.0 (0.00%) |
1.33 - 3.24 | 359,673 | 720,000 | 2,290 | ||
|
||||||||||||||||||
| 14-05-2021 | PM | LPTX | LEAP THERAPEUTICS, INC. | 96.66 | -0.12 | -0.11 | -0.55 | Leap Therapeutics reports Q1 results [5/14/2021 8:52 AM] |
1.56 | 0.08 (5.41%) |
1.51 | 0.03 (2.03%) |
1.43 - 3.24 | 309,753 | 380,000 | 10,155 | ||
|
||||||||||||||||||
| 12-03-2021 | PM | LPTX | LEAP THERAPEUTICS, INC. | 128.26 | -0.09 | -0.08 | -0.33 | Leap Therapeutics EPS in-line, misses on revenue [3/12/2021 7:20 AM] |
2.45 | 0.06 (2.51%) |
2.43 | 0.04 (1.67%) |
1.15 - 3.24 | 605,984 | 648,099 | 6,287 | ||
| 12-11-2020 | PM | LPTX | LEAP THERAPEUTICS, INC. | 95.45 | -0.09 | -0.12 | -0.33 | Leap Therapeutics EPS beats by $0.04, beats on revenue [11/12/2020 7:19 AM] |
1.54 | -0.05 (-3.14%) |
1.58 | -0.01 (-0.63%) |
0.57 - 3.18 | 686,815 | 1,136,206 | 2,417 | ||
|
|
||||||||||||||||||
| 13-08-2020 | PM | LPTX | LEAP THERAPEUTICS, INC. | 111.12 | -0.12 | -0.17 | -0.37 | Leap Therapeutics EPS beats by $0.06, misses on revenue [8/13/2020 7:12 AM] |
1.97 | 0.07 (3.68%) |
1.91 | 0.01 (0.53%) |
0.57 - 3.18 | 327,497 | 668,485 | 4,400 | ||
|
|
||||||||||||||||||